Increasing Awareness of Rare Bleeding Disorders Supports Recombinant Human Coagulation VIIa Demand
Rare bleeding disorders require specialized treatment approaches because abnormalities in blood clotting can increase the risk of prolonged or uncontrolled bleeding. Recombinant human coagulation factor VIIa is an important therapeutic option used in specific bleeding conditions. It is a laboratory-produced version of a naturally occurring clotting protein that helps initiate the blood...
0 Comments 0 Shares 27 Views 0 Reviews